Apoptosis
Research Areas
Products Related to Apoptosis(675)
- GC73093Custirsen sodiumPurity: >98.00%
Custirsen sodium inhibits the production of clusterin , an antiapoptotic protein that is upregulated in response to chemotherapy and that confers treatment resistance.
- GC73109Danvatirsen sodiumPurity: >97.00%
Danvatirsen sodium is an antisense oligonucleotide targeting STAT3 with potential antitumor activity.
- GC73112JPS014 TFAPurity: >98.00%
JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC).
- GC73129SIAIS164018 hydrochloridePurity: >99.00%
SIAIS164018 drochloride is a PROTAC-based ALK and EGFR degrader, with IC50 value of 2.5 nM and 6.6 nM for ALK and ALK G1202R, respectively.
- GC73133MisetionamideCAS: 856785-75-6Purity: >99.00%
Misetionamide is an orally oxathiazin-like compound.
- GC73138PBENZ-DBRMDCAS: 1454662-41-9Purity: >99.00%
PBENZ-DBRMD is a potent iodotronine deiodinase type 3 (DIO3) inhibitor.
- GC73225ROS-generating agent 1CAS: 2369030-41-9Purity: >99.00%
ROS-generating agent 1 (Compound 2c) covalently modifies the Sec-498 residue of TrxR to generate ROS.
- GC73232PRDX1-IN-1Purity: >98.00%
PRDX1-IN-1 is a selective inhibtor of PRDX1 with an IC50 value of 0.164 μM.
- GC73272PARP-1-IN-3CAS: 2976342-33-1Purity: >99.00%
PARP-1-IN-3, a benzamide derivative, is a potent PARP-1 inhibitor with IC50 values of 0.25 nM and 2.34 nM for PARP-1 and PARP-2, respectively.
- GC73274EGFR T790M/L858R-IN-2CAS: 2955607-40-4Purity: >99.00%
EGFR T790M/L858R-IN-2 is a potent and selective EGFRT790M/L858R inhibitor with IC50 values of 3.5, 1290 nM for EGFRT790M/L858R, EGFR WT, respectively.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC73016 | AZD4877 | 758722-49-5 | >98.00% | |
AZD4877 is another isostere to Ispinesib and also a kinesin spindle protein (Eg5) inhibitor with IC50 of 2 nM. | ||||
| GC73077 | ARI-1 | - | >99.00% | |
ARI-1 is an inhibitor of receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitor. | ||||
| GC73093 | Custirsen sodium | - | >98.00% | |
Custirsen sodium inhibits the production of clusterin , an antiapoptotic protein that is upregulated in response to chemotherapy and that confers treatment resistance. | ||||
| GC73109 | Danvatirsen sodium | - | >97.00% | |
Danvatirsen sodium is an antisense oligonucleotide targeting STAT3 with potential antitumor activity. | ||||
| GC73112 | JPS014 TFA | - | >98.00% | |
JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC). | ||||
| GC73118 | EB1 | 42951-68-8 | >99.00% | |
EB1 is the inhibitor of kinases MNK with IC50s of 0.69 μM (MNK1) and 9.4 μM (MNK2). | ||||
| GC73129 | SIAIS164018 hydrochloride | - | >99.00% | |
SIAIS164018 drochloride is a PROTAC-based ALK and EGFR degrader, with IC50 value of 2.5 nM and 6.6 nM for ALK and ALK G1202R, respectively. | ||||
| GC73133 | Misetionamide | 856785-75-6 | >99.00% | |
Misetionamide is an orally oxathiazin-like compound. | ||||
| GC73136 | VPC-70063 | 13571-44-3 | >99.00% | |
VPC-70063 is a potent Myc-Max inhibitor with an IC50 value of 8.9 μM for Myc-Max transcriptional activity inhibition. | ||||
| GC73138 | PBENZ-DBRMD | 1454662-41-9 | >99.00% | |
PBENZ-DBRMD is a potent iodotronine deiodinase type 3 (DIO3) inhibitor. | ||||
| GC73159 | KTX-582 | 2573298-13-0 | >98.00% | |
KTX-582 is a potent IRAK4 degrader with DC50 values of 4 nM and 5 nM for IRAK4 and Ikaros, respectively. | ||||
| GC73166 | U7D-1 | - | >99.00% | |
U7D-1 is a first-in-class potent and selective USP7 (ubiquitin-specific protease 7) PROTAC degrader, with a DC50 of 33 nM in RS4;11 cells. | ||||
| GC73188 | SFI003 | 2361332-90-1 | >99.00% | |
SFI003 is a SRSF3 inhibitor that drives CRC cell apoptosis via the SRSF3/DHCR24/ROS axis and exhibits potent antitumor effects both in vitro and in vivo. | ||||
| GC73199 | M47 | 890808-56-7 | >99.00% | |
M47 is a small molecule that selectively destabilizes Cryptochrome 1 (CRY1) and increases degradation of the CRY1 in the nucleus. | ||||
| GC73210 | MTR-106 | 1639357-93-9 | >99.00% | |
MTR-106 is a potent and orally active G-quadruplex stabilizer and RNA polymerase I inhibitor. | ||||
| GC73212 | TH-6 | 3031349-25-1 | >95.00% | |
TH-6 is a potent HDAC inhibitor with IC50s of 0.115, 0.135, 0.242, 0.138, 2.120 µM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, respectively. | ||||
| GC73225 | ROS-generating agent 1 | 2369030-41-9 | >99.00% | |
ROS-generating agent 1 (Compound 2c) covalently modifies the Sec-498 residue of TrxR to generate ROS. | ||||
| GC73232 | PRDX1-IN-1 | - | >98.00% | |
PRDX1-IN-1 is a selective inhibtor of PRDX1 with an IC50 value of 0.164 μM. | ||||
| GC73234 | MY-673 | 2944459-96-3 | >98.00% | |
MY-673 is a colchicine binding site inhibitor (CBSI), that inhibits tubulin polymerization. | ||||
| GC73237 | BWA-522 | 3042820-12-9 | >99.00% | |
BWA-522 is an orally available small molecule protein-targeting chimera (PROTACs) with significant degradation effect on AR-FL and AR-V7. | ||||
| GC73268 | PH14 | - | >99.00% | |
PH14 is a dual PI3K/HDAC inhibitor with IC50 values of 20.3 nM and 24.5 nM for PI3Kα and HDAC3, respectively. | ||||
| GC73269 | ABBV-467 | 2287186-66-5 | >99.00% | |
ABBV-467 is a selective MCL-1 inhibitor (Ki: <0.01 nM). | ||||
| GC73272 | PARP-1-IN-3 | 2976342-33-1 | >99.00% | |
PARP-1-IN-3, a benzamide derivative, is a potent PARP-1 inhibitor with IC50 values of 0.25 nM and 2.34 nM for PARP-1 and PARP-2, respectively. | ||||
| GC73274 | EGFR T790M/L858R-IN-2 | 2955607-40-4 | >99.00% | |
EGFR T790M/L858R-IN-2 is a potent and selective EGFRT790M/L858R inhibitor with IC50 values of 3.5, 1290 nM for EGFRT790M/L858R, EGFR WT, respectively. | ||||
